You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

26-week

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis Trial (Axatilimab, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Nov 9, 2023

Alzheimer Trial (Tricaprilin, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Mar 30, 2023

COPD (COPD) Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Mometasone furoate/formoterol (MF/F) combination
  • +3 more
  • (no location specified)
Feb 7, 2022

COPD (COPD) Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Mometasone furoate/formoterol (MF/F) combination
  • +3 more
  • (no location specified)
Feb 7, 2022

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Guangzhou (AndroidAPS-rt-CGM;, sensor augmented pump(SAP);)

Recruiting
  • Diabetes Mellitus
  • +6 more
  • AndroidAPS-rt-CGM;
  • sensor augmented pump(SAP);
  • Guangzhou, Guangdong, China
    Jinhua Yan
Feb 12, 2023

Overweight or Obesity Trial in Linköping, Solna, Uppsala, (EMP16-120/40, MR orlistat 120 mg, Conventional orlistat 120 mg,)

Recruiting
  • Overweight or Obesity
  • Linköping, Sweden
  • +2 more
Jun 28, 2023

Asthma Trial (Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol

Completed
Has Results
  • Asthma
  • Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Asthma Trial (mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg,

Completed
Has Results
  • Asthma
  • mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Type 2 Diabetes Trial in Beijing (HR17031 injection, INS068 injection, SHR20004 injection)

Recruiting
  • Type 2 Diabetes
  • HR17031 injection
  • +2 more
  • Beijing, Beijing, China
    Peking university People's Hospital
Jul 25, 2022

Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (HOE901)
  • +5 more
  • China, China
    CHINA
Apr 21, 2022

Asthma Trial in Nyíregyháza (Administration via pressurized metered dose inhaler (pMDI))

Recruiting
  • Asthma
  • Administration via pressurized metered dose inhaler (pMDI)
  • Nyíregyháza, Hungary
    Simplex Kft
Mar 14, 2022

Decompensated Cirrhosis and Ascites Trial in Odense, Frankfurt (Human albumin, sodium chloride)

Not yet recruiting
  • Decompensated Cirrhosis and Ascites
  • Human albumin
  • sodium chloride
  • Odense, Denmark
  • +1 more
Sep 20, 2021

Obesity Trial in Worldwide (Placebo, PF-06882961)

Active, not recruiting
  • Obesity
  • Anniston, Alabama
  • +40 more
Jun 29, 2022

Mild to Moderate Alzheimer's Disease Trial in United States (AR1001, Placebo)

Completed
  • Mild to Moderate Alzheimer's Disease
  • Banning, California
  • +20 more
Jul 19, 2021

Episodic Migraine, Migraine Disorders Trial in Matosinhos (Electronic Headache Diary, Paper Diary)

Recruiting
  • Episodic Migraine
  • Migraine Disorders
  • Electronic Headache Diary
  • Paper Diary
  • Matosinhos, Porto, Portugal
    Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos
Mar 30, 2021

Alzheimer's Disease Trial (Tricaprilin, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • (no location specified)
Jun 11, 2021

Osteoarthritis Trial in Toronto (Durolane)

Completed
  • Osteoarthritis
  • Durolane
  • Toronto, Ontario, Canada
    St. Michaels Hospital
Feb 12, 2021

COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Godollo, Hungary
    Erzsebet Gondozohaz
Oct 28, 2021

Osteoarthritis Trial in China (Hylan G-F 20 (GZ402662/SAR402662), Placebo)

Completed
Has Results
  • Osteoarthritis
  • Hylan G-F 20 (GZ402662/SAR402662)
  • Placebo
  • Beijing, China
  • +20 more
Mar 15, 2022

Bipolar Disorder Trial (ziprasidone oral capsules)

Withdrawn
  • Bipolar Disorder
  • ziprasidone oral capsules
  • (no location specified)
Feb 18, 2021

Post Partum Depression, Perinatal Depression, Post Partum Anxiety Trial in Iowa City (Baseline Assessment (18-26 weeks

Recruiting
  • Post Partum Depression
  • +3 more
  • Baseline Assessment (18-26 weeks pregnant)
  • +3 more
  • Iowa City, Iowa
    University of Iowa
May 16, 2022

Bipolar Disorder Trial in United States (Ziprasidone, Placebo)

Terminated
Has Results
  • Bipolar Disorder
  • Orange City, Florida
  • +8 more
Jun 15, 2021

Parkinson's Disease, Levodopa Induced Dyskinesia (LID) Trial in Worldwide (amantadine HCl ER, Placebo)

Terminated
Has Results
  • Parkinson's Disease
  • Levodopa Induced Dyskinesia (LID)
  • amantadine HCl ER
  • Placebo
  • Tucson, Arizona
  • +55 more
Feb 14, 2022

Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)

Completed
Has Results
  • Growth Hormone Deficiency, Pediatric
  • +3 more
  • TransCon hGH
  • Birmingham, Alabama
  • +23 more
Dec 7, 2021

Type 2 Diabetes Trial in Halland, Skåne, Västra Götaland (Standard of Care with EASY DSS, Standard of Care without EASY DSS)

Completed
  • Type 2 Diabetes Mellitus
  • Standard of Care with EASY DSS
  • Standard of Care without EASY DSS
  • Halland, Sweden
  • +2 more
Sep 30, 2020